I now have comprehensive, detailed information from multiple major textbooks. Let me compile a thorough, well-structured response.
Management of Anaphylaxis
Anaphylaxis is a severe, life-threatening systemic hypersensitivity reaction driven by mast cell and basophil degranulation, releasing histamine, tryptase, prostaglandin D2, and leukotriene C4. The principal target organs are cardiovascular, cutaneous, respiratory, and gastrointestinal. Rapid recognition and immediate epinephrine administration are the cornerstones of management.
Diagnosis
Anaphylaxis is primarily a clinical diagnosis. It is highly likely when any one of the following three criteria is met:
- Acute onset of an illness with skin/mucosal involvement AND at least one of: respiratory compromise or reduced BP/end-organ dysfunction
- Two or more of the following occurring rapidly after exposure to a likely allergen: skin/mucosal symptoms, respiratory compromise, reduced BP, or persistent GI symptoms
- Reduced BP after exposure to a known allergen for that patient
Common triggers: Foods (peanuts, tree nuts, shellfish), medications (antibiotics, NSAIDs, radiocontrast media, chemotherapy, biologics), insect stings (hymenoptera), latex, and exercise. In up to 20% of cases, no trigger is identified (idiopathic).
Serum tryptase peaks at ~1 hour after onset and may remain elevated for up to 4 hours - useful for retrospective confirmation but should not delay treatment.
Immediate Emergency Management (Box 106.7, Rosen's EM)
Step 1 - Simultaneous Emergency Measures
- Remove the triggering agent if identifiable (e.g., stop IV drug infusion, remove insect stinger)
- Position: Place patient supine; elevate legs if hypotensive. Sitting the patient upright at onset is associated with worse outcomes
- Begin cardiac monitoring, pulse oximetry, and BP monitoring
- Establish large-bore IV access (16-18 gauge preferred)
- Administer supplemental oxygen
- Prepare for endotracheal intubation (early intubation is critical if angioedema threatens the airway - delay risks complete obstruction)
- Begin rapid infusion of isotonic crystalloid (normal saline):
- Adults: 1000 mL IV in first 5 min (several liters may be required)
- Pediatrics: 20-30 mL/kg IV increments
Drug Treatment
First-Line: Epinephrine (IMMEDIATE - No Absolute Contraindications)
Epinephrine is the only first-line drug. It must not be delayed, replaced, or preceded by antihistamines or steroids.
Mechanism: α1 - vasoconstriction + reduces mucosal edema; β1 - increased HR and cardiac contractility; β2 - bronchodilation and mast cell stabilization
| Route | Adult Dose | Pediatric Dose |
|---|
| IM (preferred) - anterolateral thigh | 0.3-0.5 mg (0.3-0.5 mL of 1:1000/1 mg/mL solution) q5-10 min | 0.01 mg/kg (max 0.5 mg) IM q5-10 min |
| Autoinjector | EpiPen 0.3 mg (adults) | EpiPen Jr 0.15 mg (children <30 kg) |
| IV bolus (cardiovascular collapse) | 100 mcg over 5-10 min (mix 0.1 mg in 10 mL NS) | - |
| IV infusion (refractory) | Start at 1 mcg/min; titrate to max 10 mcg/min (1 mg in 1000 mL NS/D5W = 1 mcg/mL) | 0.1-1.5 mcg/kg/min; titrate |
Key points:
- IM into the anterolateral thigh achieves higher, faster, and more consistent peak plasma levels than deltoid or SC injection
- SC injection is no longer recommended - IM is superior
- IV epinephrine carries risk of dysrhythmia; requires careful cardiac monitoring and dilution
- Central venous access is preferred for IV infusion to avoid tissue necrosis from extravasation
- There is no absolute contraindication in anaphylaxis, including in patients with cardiovascular disease - benefits far outweigh risks
- Most patients need only a single IM dose
Second-Line Agents (After Epinephrine - Never Instead of It)
H1 Antihistamines
Relieve urticaria and pruritus but have no immediate effect on the anaphylactic reaction itself:
| Drug | Adult | Pediatric |
|---|
| Diphenhydramine (H1) | 25-50 mg IV/IM/PO q6h | 1 mg/kg IV/IM/PO q6h |
| Cetirizine (H1) | 10 mg oral or IV | 5-10 mg oral or IV |
H2 Antihistamines
| Drug | Adult | Pediatric |
|---|
| Famotidine | 40 mg IV | 0.5 mg/kg IV over 5 min |
| Ranitidine | 50 mg IV over 5 min | 0.5 mg/kg IV over 5 min |
| Cimetidine | 300 mg IV | 4-8 mg/kg IV |
Corticosteroids
No significant immediate effect and do not reliably prevent biphasic reactions, but are given to attenuate prolonged reactions:
| Drug | Adult | Pediatric |
|---|
| Hydrocortisone | 250-500 mg IV | 5-10 mg/kg IV (max 500 mg) |
| Methylprednisolone | 80-125 mg IV | 1-2 mg/kg IV (max 125 mg) |
| Prednisone (oral) | 40-60 mg PO daily for 3-5 days | 1-2 mg/kg/day for 3-5 days |
For Bronchospasm (In Addition to Epinephrine)
Albuterol (salbutamol):
- Adults: 2.5-5 mg nebulized (diluted to 3 mL NS), or 4-6 puffs MDI, q20 min as needed
- Pediatric: 1.25-2.5 mg nebulized q20 min
Ipratropium:
- Adults: 0.5 mg in 3 mL NS nebulized
For Refractory Anaphylaxis
Refractory to IM Epinephrine + Fluids
Initiate IV epinephrine infusion as above. If dangerous dysrhythmias or tachycardia limit epinephrine use, consider other vasopressors:
| Vasopressor | Dose |
|---|
| Dopamine | 5-20 mcg/kg/min continuous IV infusion |
| Norepinephrine | 0.05-0.5 mcg/kg/min |
| Phenylephrine | 1-5 mcg/kg/min |
| Vasopressin | 0.01-0.4 units/min |
Patients on Beta-Blockers
Epinephrine may have blunted effect due to β-receptor blockade, and may cause severe hypertension from unopposed α-stimulation. Use glucagon:
- Dose: 1-5 mg IV bolus slowly over 5 min, then 5-15 mcg/min IV infusion, titrated to clinical response
- Monitor for nausea and vomiting (side effects of glucagon)
Airway Management
- Early intubation is preferred if there is evidence of angioedema-related respiratory distress - any delay risks complete obstruction
- Prepare for adjunct airway techniques: awake fiberoptic intubation, surgical airway (cricothyrotomy)
- If laryngeal edema is not rapidly responsive to epinephrine, cricothyroidotomy or tracheotomy may be required
- Maintain O2 saturation >90%
Positioning
- Supine with legs elevated (Trendelenburg) is standard
- If respiratory distress or vomiting, modify to semi-recumbent
- Never allow the patient to stand or sit suddenly - "empty caval syndrome" (positional cardiovascular collapse) can cause fatal cardiac arrest when moving from supine to upright
Disposition and Observation
Biphasic anaphylaxis (recurrence of symptoms 1-72 hours after initial resolution) occurs in up to 5-23% of cases. Patients should be observed after symptom resolution.
Observation period guidelines:
| Clinical Scenario | Recommended Observation |
|---|
| Mild reaction, resolved, otherwise healthy | Minimum 1 hour asymptomatic |
| Typical anaphylaxis | 4-6 hours |
| Severe/protracted anaphylaxis | 6-24 hours or admission |
| Received IV epinephrine or >1 dose IM | Prolonged observation or admission |
| High-risk features (asthma, prior severe reaction, beta-blocker use, elderly, lives alone) | Prolonged observation or admit |
Indications for hospital admission:
- Protracted anaphylaxis or refractory hypotension
- Airway involvement
- Unknown trigger
- IV epinephrine required
- More than one dose of IM epinephrine given
- Poor social support or lives alone far from medical care
Discharge Planning
Every patient discharged after anaphylaxis must receive:
- Epinephrine autoinjector (at least 2 prescribed; carry at all times and store at multiple locations - home, vehicle, work)
- Antihistamines: Diphenhydramine 25-50 mg PO q6-8h for 3-5 days
- Corticosteroids: Prednisone 40-60 mg PO daily (or 20-30 mg BID) for 3-5 days
- Written emergency action plan
- Education on: recognizing anaphylaxis, allergen avoidance, proper use of autoinjector (fewer than 1/3 of patients can demonstrate correct use without instruction), wearing a MedicAlert bracelet
- Referral to allergist/immunologist for trigger identification and desensitization planning
- Patients on beta-blockers should have their antihypertensive switched to a different drug class
Special Situations
Perioperative Anaphylaxis
- Frequency: ~1 in 2,000-10,000 cases
- Common triggers: neuromuscular blocking agents, antibiotics, latex, chlorhexidine, induction agents
- Management is the same; maintain high index of suspicion intraoperatively
Radiocontrast Anaphylaxis - Pre-medication Protocol
For patients with prior contrast reaction requiring re-exposure:
- Prednisone 50 mg PO at 13, 7, and 1 hour before procedure
- Diphenhydramine 50 mg PO 1 hour before procedure
- Consider ephedrine 25 mg PO 1 hour before
- Consider famotidine 20 mg PO 3 hours before
Non-histaminergic Angioedema (Hereditary Angioedema / ACE-inhibitor angioedema)
- Does not reliably respond to epinephrine and antihistamines (though these should still be tried initially)
- Specific agents for hereditary angioedema (HAE):
- Icatibant (bradykinin B2 receptor antagonist)
- Ecallantide (plasma kallikrein inhibitor)
- Human or recombinant C1 esterase inhibitor
- Fresh frozen plasma (FFP) as an alternative
Summary: Priority Hierarchy
ANAPHYLAXIS SUSPECTED
↓
1. EPINEPHRINE IM (anterolateral thigh) - IMMEDIATELY
↓
2. Supine position + O2 + IV access + fluids
↓
3. Monitor: cardiac, SpO2, BP
↓
4. Airway: early intubation if angioedema threatens
↓
5. If refractory: IV epinephrine infusion ± vasopressors
If on β-blocker: add Glucagon
↓
6. Second-line: antihistamines + corticosteroids + bronchodilators
↓
7. Observe 4-6h minimum; admit if severe
↓
8. Discharge: EpiPen + steroids + antihistamines + allergist referral
Sources: ROSEN's Emergency Medicine (9e), p. 2386-2395 | Tintinalli's Emergency Medicine (9e), pp. 108-114 | The Washington Manual of Medical Therapeutics, p. 427 | Goldman-Cecil Medicine (26e), Chapter 233 | Textbook of Family Medicine (9e)